The clinical pharmacogenetics implementation consortium (CPIC): facilitating the adoption of pharmacogenetics into routine clinical practice and the electronic health record.

被引：0
|
作者：
Caudle, Kelly E. [1 ]
Hoffman, James M. [1 ]
Whirl-Carrillo, Michelle [2 ]
Haidar, Cyrine E. [1 ]
Crews, Kristine R. [1 ]
Klein, Teri E. [2 ]
Relling, Mary V. [1 ]
机构：
[1] St Jude Childrens Res Hosp, Dept Pharmaceut Sci, Memphis, TN 38105 USA
[2] Stanford Univ, Dept Genet, Stanford, CA 94305 USA
来源：
PHARMACOTHERAPY | 2014年 / 34卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
286
引用
收藏
页码：E251 / E252
页数：2
相关论文
共 50 条
  • [31] Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for human leukocyte antigen B (HLA-B) genotype and allopurinol dosing: 2015 update
    Saito, Y.
    Stamp, L. K.
    Caudle, K. E.
    Hershfield, M. S.
    McDonagh, E. M.
    Callaghan, J. T.
    Tassaneeyakul, W.
    Mushiroda, T.
    Kamatani, N.
    Goldspiel, B. R.
    Phillips, E. J.
    Klein, T. E.
    Lee, M. T. M.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2016, 99 (01) : 36 - 37
  • [32] Pharmacogenetics: The perspective of a routine use of pharmacogenetic testing in psychiatric clinical practice
    Ielmini, Marta
    Caselli, Ivano
    Poloni, Nicola
    Callegari, Camilla
    PSYCHIATRY RESEARCH, 2021, 305
  • [33] Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for CYP2C19 and Voriconazole Therapy (vol 102, pg 45, 2017)
    Moriyama, B.
    Obeng, A. O.
    Barbarino, J.
    Penzak, S.
    Henning, S.
    Scott, S.
    Agundez, J.
    Wingard, J.
    McLeod, H.
    Klein, T.
    Cross, S.
    Caudle, K.
    Walsh, T.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2018, 103 (02) : 349 - 349
  • [34] Clinical Pharmacogenetics Implementation Consortium Guidelines for Thiopurine Methyltransferase Genotype and Thiopurine Dosing
    Relling, M. V.
    Gardner, E. E.
    Sandborn, W. J.
    Schmiegelow, K.
    Pui, C-H
    Yee, S. W.
    Stein, C. M.
    Carrillo, M.
    Evans, W. E.
    Klein, T. E.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2011, 89 (03) : 387 - 391
  • [35] Comparison of FDA Table of Pharmacogenetic Associations and Clinical Pharmacogenetics Implementation Consortium guidelines
    Pritchard, Daryl
    Patel, Jai N.
    Stephens, Lindsay E.
    McLeod, Howard L.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2022, 79 (12) : 993 - 1005
  • [36] Clinical Pharmacogenetics Implementation Consortium Guidelines for Dihydropyrimidine Dehydrogenase Genotype and Fluoropyrimidine Dosing
    Caudle, K. E.
    Thorn, C. F.
    Klein, T. E.
    Swen, J. J.
    McLeod, H. L.
    Diasio, R. B.
    Schwab, M.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2013, 94 (06) : 640 - 645
  • [37] CIPHEROME ALGORITHM MORE ACCURATELY CORRELATES WITH ADVERSE DRUG REACTIONS (ADRS) TO WARFARIN THAN CLINICAL PHARMACOGENETICS IMPLEMENTATION CONSORTIUM (CPIC) GUIDELINES.
    Chiang, J.
    Lee, I.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2020, 107 : S32 - S33
  • [38] From pharmacogenetics to clinical tests: The role of electronic health records
    Perlis, R.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2014, 17 : 35 - 35
  • [39] Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for IFNL3 (IL28B) Genotype and PEG Interferon-α-Based Regimens
    Muir, A. J.
    Gong, L.
    Johnson, S. G.
    Lee, M. T. M.
    Williams, M. S.
    Klein, T. E.
    Caudle, K. E.
    Nelson, D. R.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2014, 95 (02) : 141 - 146
  • [40] Translating pharmacogenetics from research to routine clinical practice – a survey of the IGNITE Network
    Kenneth D. Levy
    R. Ryanne Wu
    Daisuke Goto
    Michelle A. Ramos
    Victoria M. Pratt
    J. Kevin Hicks
    Ebony B. Madden
    Gillian C. Bell
    Kathryn V. Blake
    Michelle Cohen
    Benjamin Q. Duong
    James P. Franciosi
    Lori A. Orlando
    Kunal Sanghavi
    Geoffrey S. Ginsburg
    Translational Medicine Communications, 5 (1)
12345